Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,948 | 41,918 | 45,204 | 100,444 | 178,872 |
| Marketable Securities | N/A | N/A | 35,798 | 177,188 | 197,676 |
| Receivables | 371 | 526 | 923 | 4,472 | 6,362 |
| Other current assets | 10,142 | 4,072 | 3,144 | 0 | 0 |
| TOTAL | $35,830 | $51,691 | $94,328 | $300,327 | $398,769 |
| Non-Current Assets | |||||
| PPE Net | 11,042 | 17,887 | 26,874 | 63,531 | 51,523 |
| Investments And Advances | 0 | 0 | 0 | 29,845 | 88,169 |
| Intangibles | 0 | 0 | 0 | 88,281 | 93,462 |
| Other Non-Current Assets | 12,873 | 32,057 | 44,118 | 80,525 | 90,000 |
| TOTAL | $23,915 | $49,944 | $70,992 | $262,182 | $323,154 |
| Total Assets | $59,745 | $101,635 | $165,320 | $562,509 | $721,923 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,437 | 15,485 | 15,259 | 22,418 | 9,759 |
| Accrued Expenses | 17,721 | 14,569 | 8,918 | 21,506 | 20,840 |
| TOTAL | $42,466 | $45,805 | $47,731 | $111,711 | $127,887 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 899 | 7,556 | 0 | 51,780 | 85,711 |
| Other Non-Current Liabilities | 25,673 | 27,186 | 34,702 | 40,193 | 45,283 |
| TOTAL | $31,547 | $33,060 | $34,702 | $155,840 | $218,693 |
| Total Liabilities | $74,013 | $78,865 | $82,433 | $267,551 | $346,580 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 414,274 | 224,710 | 178,906 | 168,483 | 145,968 |
| Common Shares | 3,507 | 2,128 | 1,781 | 1,668 | 1,459 |
| Retained earnings | -1,627,249 | -1,504,317 | -1,406,376 | -1,148,545 | -956,267 |
| Other shareholders' equity | -1,464 | -7,530 | -4,595 | -8,404 | -3,987 |
| TOTAL | $-14,268 | $22,770 | $82,887 | $294,958 | $375,343 |
| Total Liabilities And Equity | $59,745 | $101,635 | $165,320 | $562,509 | $721,923 |